113 related articles for article (PubMed ID: 27438675)
1. Reversal of the Migratory and Invasive Phenotype of Ras-Transfected Mammary Cells by Photodynamic Therapy Treatment.
Calvo G; Sáenz D; Simian M; Sampayo R; Mamone L; Vallecorsa P; Batlle A; Casas A; Di Venosa G
J Cell Biochem; 2017 Mar; 118(3):464-477. PubMed ID: 27438675
[TBL] [Abstract][Full Text] [Related]
2. Changes in actin and E-cadherin expression induced by 5-aminolevulinic acid photodynamic therapy in normal and Ras-transfected human mammary cell lines.
Di Venosa G; Rodriguez L; Mamone L; Gándara L; Rossetti MV; Batlle A; Casas A
J Photochem Photobiol B; 2012 Jan; 106():47-52. PubMed ID: 22075381
[TBL] [Abstract][Full Text] [Related]
3. Ras-transfected human mammary tumour cells are resistant to photodynamic therapy by mechanisms related to cell adhesion.
Rodriguez L; Di Venosa G; Rivas MA; Juarranz A; Sanz-Rodriguez F; Casas A
Life Sci; 2023 Feb; 314():121287. PubMed ID: 36526044
[TBL] [Abstract][Full Text] [Related]
4. Response to ALA-based PDT in an immortalised normal breast cell line and its counterpart transformed with the Ras oncogene.
Rodriguez L; Divenosa G; Batlle A; Macrobert A; Casas A
Photochem Photobiol Sci; 2007 Dec; 6(12):1306-10. PubMed ID: 18046486
[TBL] [Abstract][Full Text] [Related]
5. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
6. Meta-tetrahydroxyphenyl chlorine mediated photodynamic therapy inhibits the migration and invasion of a nasopharyngeal carcinoma KJ-1 cell line.
Wang CP; Lou PJ; Lo FY; Shieh MJ
J Formos Med Assoc; 2014 Mar; 113(3):173-8. PubMed ID: 24630035
[TBL] [Abstract][Full Text] [Related]
7. Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials.
Abdulrehman G; Xv K; Li Y; Kang L
Lasers Med Sci; 2018 Sep; 33(7):1581-1590. PubMed ID: 29796953
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
Marques LA; Semprebon SC; Niwa AM; D'Epiro GF; Sartori D; de Fátima Â; Ribeiro LR; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1279-1288. PubMed ID: 27592117
[TBL] [Abstract][Full Text] [Related]
9. Expression of proapoptotic BAX and TP53 genes and antiapoptotic BCL-2 gene in MCF-7 and T-47D tumour cell cultures of the mammary gland after a photodynamic therapy with photolon.
Płonka J; Latocha M; Kuśmierz D; Zielińska A
Adv Clin Exp Med; 2015; 24(1):37-46. PubMed ID: 25923085
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic effects in vitro in fresh gynecologic tumors analyzed with a bioluminescence method.
Schlosser V; Koechli OR; Cattaneo R; Jentsch B; Haller U; Walt H
Clin Chem Lab Med; 1999 Feb; 37(2):115-20. PubMed ID: 10219498
[TBL] [Abstract][Full Text] [Related]
11. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
[TBL] [Abstract][Full Text] [Related]
12. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid.
Akens MK; Wise-Milestone L; Won E; Schwock J; Yee AJ; Wilson BC; Whyne CM
Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):426-33. PubMed ID: 25176573
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch precancerous lesions by topical 5-aminolevulinic acid-mediated photodynamic therapy.
Hsu YC; Yang DF; Chiang CP; Lee JW; Tseng MK
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):310-8. PubMed ID: 23200011
[TBL] [Abstract][Full Text] [Related]
17. No cross-resistance between ALA-mediated photodynamic therapy and nitric oxide.
Di Venosa G; Casas A; Fukuda H; Perotti C; Batlle A
Nitric Oxide; 2005 Nov; 13(3):155-62. PubMed ID: 16115785
[TBL] [Abstract][Full Text] [Related]
18. m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
Hornung R; Walt H; Crompton NE; Keefe KA; Jentsch B; Perewusnyk G; Haller U; Köchli OR
Photochem Photobiol; 1998 Oct; 68(4):569-74. PubMed ID: 9796440
[TBL] [Abstract][Full Text] [Related]
19. ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells.
Tsai T; Ji HT; Chiang PC; Chou RH; Chang WS; Chen CT
Lasers Surg Med; 2009 Apr; 41(4):305-15. PubMed ID: 19347942
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
